Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$79.5M
+8.2% from 2023
Prescriptions
928
$85,617.65 per claim
Patients
94
76 prescribers
Total spending, 2024
$79.5M
$845,246.57 per patient
Medicare prescription drug plans paid $79.5M for Ravicti in 2024, for 928 prescriptions and refills to 94 patients (up 8.2% from 2023). The average cost per claim was $85,617.65.
California had the highest Medicare cost for Ravicti in 2024: $13.7M for 130 claims, followed by Texas ($7.1M).
Holly Bernal, nurse practitioner in Palo Alto, CA, had the highest Medicare cost for Ravicti in 2024: 29 claims costing $4.3M.
Ravicti is made by Amgen Inc. (AMGN), listed in the Medicare spending data as Horizon/Amgen.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Holly Bernal Palo Alto, CA | Nurse Practitioner | 29 | Under 11 | $4.3M |
| Susan A Berry Minneapolis, MN | Pediatric Medicine | 48 | Under 11 | $3.7M |
| Markey C McNutt II |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 69 | 760 | 79 | $66.5M |
| 2023 | 75 | 810 | 87 | $73.5M |
| 2024 | 76 | 928 | 94 | $79.5M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Medical Genetics and Genomics |
| 41 |
| Under 11 |
| $3.3M |
| Kim Choong Wen Ng Philadelphia, PA | Pediatric Medicine | 40 | Under 11 | $2.8M |
| Amy C Yang Portland, OR | Pediatric Medicine | 13 | Under 11 | $2.6M |
| Brendan Lee Houston, TX | Medical Genetics and Genomics | 23 | Under 11 | $2.3M |
| Margo S Breilyn Bronx, NY | Medical Genetics and Genomics | 26 | Under 11 | $2.3M |
| Bryan E Hainline Indianapolis, IN | Pediatric Medicine | 24 | Under 11 | $2.3M |
| Amarilis Sanchez-Valle Tampa, FL | Medical Genetics and Genomics | 24 | Under 11 | $2.3M |
| Ada Hamosh Baltimore, MD | Medical Genetics and Genomics | 23 | Under 11 | $2.3M |
| Jaya B Ganesh New York, NY | Pediatric Medicine | 29 | Under 11 | $2.2M |
| Hans Andersson New Orleans, LA | Pediatric Medicine | 26 | Under 11 | $2.2M |
| Chung U Lee Palo Alto, CA | Pediatric Medicine | 21 | Under 11 | $2.0M |
| Dorothy K Grange Saint Louis, MO | Medical Genetics and Genomics | 15 | Under 11 | $1.9M |
| Madelena M Martin Sacramento, CA | Medical Genetics and Genomics | 18 | Under 11 | $1.9M |
| David A Sweetser Boston, MA | Hematology-Oncology | 23 | Under 11 | $1.6M |
| Laura L Konczal Cleveland, OH | Pediatric Medicine | 13 | Under 11 | $1.5M |
| Richard J Schroer North Charleston, SC | Pediatric Medicine | 16 | Under 11 | $1.5M |
| Hind Alsharhan Miami, FL | Medical Genetics and Genomics | 12 | Under 11 | $1.4M |
| Nancy D Leslie Cincinnati, OH | Pediatric Medicine | 23 | Under 11 | $1.4M |
| Mari Mori Atlanta, GA | Medical Genetics and Genomics | 15 | Under 11 | $1.3M |
| Michele Spencer-Manzon New Haven, CT | Internal Medicine | 14 | Under 11 | $1.3M |
| Bianca E Russell Los Angeles, CA | Pediatric Medicine | 24 | Under 11 | $1.2M |
| Cheryl L Garganta Gainesville, FL | Medical Genetics and Genomics | 17 | Under 11 | $1.2M |
| Walla Al-Hertani Orange, CA | Medical Genetics and Genomics | 11 | Under 11 | $1.1M |
| Manufacturer | Claims | Spending |
|---|---|---|
| Horizon/Amgen AMGN | 928 | $79.5M |